Rodec Pharma IPO Details
MAINBOARD
Rodec Pharma IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.
Rodec Pharma IPO total issue size comprises 56,50,000 shares (aggregating up to ₹0.00 Cr.). This includes a fresh issue of 56,50,000 shares (aggregating up to ₹0.00 Cr.). Pre-issue shareholding stands at 2,25,84,800, which will increase to 2,25,84,800 post-issue.
The Lead Managers for Rodec Pharma IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Khambatta Securities Ltd.. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Rodec Pharma Limited DRHP.
Rodec Pharma IPO Details
Rodec Pharma IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Rodec Pharma IPO Reservation
Promoter Holding
Documents
Rodec Pharma IPO Valuations
Rodec Pharma Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.07 | 71.99 | 50.62 | 44.13 |
| Total Income | 63.71 | 108.19 | 89.61 | 71.72 |
| Profit After Tax | 9.73 | 18.26 | 11.04 | 5.21 |
| EBITDA | 13.39 | 25.76 | 15.73 | 8.12 |
| Reserves and Surplus | 37.11 | 49.86 | 31.60 | 20.57 |
| Amount in ₹ Crore | ||||
About Rodec Pharma IPO
Rodec Pharma Ltd. was incorporated in 1997 and is engaged in the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs and animal feed supplements for the animal healthcare sector. The Company caters to the needs of livestock owners, veterinarians, and distributors through a diversified product portfolio and an established distribution network.
Rodec Pharma Ltd. operates an integrated business model encompassing manufacturing, distribution, and marketing, enabling efficient supply of products to end users across multiple regions. This integrated approach supports quality control, timely availability, and market responsiveness.
The Company’s product portfolio comprises veterinary pharmaceutical drugs and animal feed supplements, with 35 products and 29 variants across key therapeutic and nutritional categories, including antibiotics, antispasmodics, ectoparasiticides, and nutritional supplements.
Rodec Pharma Ltd. has developed a pan-India distribution footprint, with presence across several states, including Maharashtra, Haryana, Uttar Pradesh, Punjab, Gujarat, Rajasthan, Assam, Madhya Pradesh, Telangana, Chhattisgarh, Bihar, Jharkhand, Uttarakhand, Himachal Pradesh, and West Bengal, enabling broad market access and customer reach.
As of the reporting period, the Company employed 602 personnel, supporting its manufacturing operations, sales and marketing, distribution, and administrative functions.
With its integrated operations, diversified product range, and extensive distribution network, Rodec Pharma Ltd. is positioned to serve the growing demand in India’s animal healthcare and nutrition markets.
Strength Of Rodec Pharma IPO
Risk Of Rodec Pharma IPO
Objectives Rodec Pharma IPO
To be announced
Company Contact Details
Rodec Pharma Ltd. Address
C-2, Site-3
Meerut Road Industrial Area,
Ghaziabad, Uttar Pradesh, 201001
Email: cs@rodec.in
Website: https://www.rodec.in/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Rodec Pharma IPO - FAQs
The Rodec Pharma IPO is a MAINBOARD public issue comprising 5650000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹0.00 Cr.. The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.
The IPO opens for subscription on TBA, and closes on TBA.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at TBA.